Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.37
-0.45 (-6.60%)
At close: Aug 13, 2025, 4:00 PM
6.47
+0.10 (1.57%)
Pre-market: Aug 14, 2025, 9:05 AM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $162.16 million as of August 14, 2025. Its market cap has increased by 35.29% in one year.
Market Cap
162.16M
Enterprise Value
135.37M
1-Year Change
35.29%
Ranking
Category
Stock Price
$6.37
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $162.16M, an increase of 179.56%. That is a compound annual growth rate of 33.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 162.16M | 55.14% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 584.42B |
| Johnson & Johnson | 416.96B |
| AbbVie | 348.06B |
| UnitedHealth Group | 230.42B |
| Abbott Laboratories | 228.21B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |